My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more
Category - Investments and funding
Goodbye 2022 – Hello 2023
We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more
Time Is What We Want Most – Why Wasting Any More of It?
As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more